Poster Presentation Society of Obstetric Medicine of Australia and New Zealand ASM 2015

To Treat or Not to Treat – A Management Dilemma in an Asymptomatic Patient with a Rare, but Frequently Fatal, Cardiac Arrhythmic Disease. (#217)

Annie V Kroushev 1 , Emily Kotschet 1 , Vangy Malkoutzis 1 , Ivan Macciocca 2 , Euan Wallace 1
  1. Monash Medical Centre, Clayton, VIC, Australia
  2. Victorian Clinical Genetics Services, Parkville, Victoria, Australia
Publish consent withheld
  1. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69–74.
  2. Beery TA, Shah MJ, Benson DW, Genetic characterization of familial CPVT after 30 years., Biol Res Nurs. 2009 Jul;11(1):66-72
  3. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196–200.
  4. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932-1963.
  5. Walker NL1, Cobbe SM, McGavigan AD, Paroxysmal bidirectional ventricular tachycardia with tachycardiomyopathy in a pregnant woman, Acta Cardiol. 2009 Jun;64(3):419-22.